表紙
市場調查報告書

眼科相關企業的契約趨勢調查:合併與收購、資金調集、業務和技術出售

2018/2019 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales

出版商 Market Scope, LLC 商品編碼 644816
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
眼科相關企業的契約趨勢調查:合併與收購、資金調集、業務和技術出售 2018/2019 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales
出版日期: 2019年12月23日內容資訊: 英文
簡介

本報告討論了2018年和2019年進行的108件眼科相關企業資本交易,其中包括風險投資、私人股權投資、公開發行增資的投資及企業出售。本調查報告具備許多新特徵,包含有眼科相關市場各部門相關詳細分析等,也分析了各部門的交易件數及整體件數、與其他部門比較的分配、用途別、種類別資金、在各部門募集最多資金的企業。

此外,也有對於眼科領域中美國衛生研究院 (NIH) 等的研究補助金的相關豐富分析,加上現在正在開發中的視網膜疾病基因治療一覽,總共新追加57個圖表。

2018/2019年版報告的特徵

本調查領域不只分析對眼科領域的投資,也提供利於評估各種技術市場價值的資訊,可以為眼科相關新創企業的投資額及業績佐證。報告中包括風險投資、公開發行、授權租用、目標達成獎勵金、產品與企業的出售、主要借款等,在2018年與2019年1月到10月的期間進行的眼科相關新創的豐富投資資訊。

  • 資本交易的資金用途別分類:新創企業、消費證券、企業出售、授權料支付
  • 4種投資型態分析:策略性投資家、風險投資、公開發行、私人股權投資
  • 在眼科相關7部門有關交易的詳細分析:乾眼症、視網膜疾病、青光眼、白內障、診斷、眼角膜、折射功能及各部門的主要投資家與交易
  • 資本交易的主要指標:正在調集資金的企業、正在進行投資的企業、募集了最多資金的企業的相關指標
  • 本調查報告所討論的企業:78家企業與調集的資金總額,以及調集了超過契約規模中央值的資金的46家企業概要
目錄

Our 2018/2019 Ophthalmic Deals Book covers 108 ophthalmic company transactions in 2018 and 2019, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. There are many new features in the 2019 version of this report, including a detailed analysis of each ophthalmic sector. This analysis reviews sector transaction counts and totals, sector allocation compared with other ophthalmic sectors, sector funds by use and type, and the top funded companies in each sector.

Also new in the 2019 version is an analysis of NIH and other grants to ophthalmology. A comprehensive list of retinal disease gene therapies in development and an additional 57 tables and figures are also new in 2019.

What's New

Our 2018/2019 Ophthalmic Deals Book covers 108 ophthalmic company transactions in 2018 and 2019, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. There are many new features in the 2019 version of this report, including a detailed analysis of each ophthalmic sector. This analysis reviews sector transaction counts and totals, sector allocation compared with other ophthalmic sectors, sector funds by use and type, and the top funded companies in each sector.

Market Scope's "2018/20198 Ophthalmic Deals Book" analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures. The information covers investments in ophthalmic ventures in 2018 and the first 10 months of 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. Also included:

  • Transactions categorized by fund use: new venture, commercial equity, sale of companies, and license payments.
  • Four investment types are analyzed in this report: strategic investors, venture capital, public offerings, and private equity.
  • Detailed transaction analysis provided for seven ophthalmic sectors: dry eye, retina, glaucoma, cataract, diagnostic, cornea, and refractive. Key investors and transactions in each sector are included.
  • Key metrics in this report include: companies raising funds, companies making investments, and top funded companies.
  • Company coverage: 78 companies, along with total funds earned, are included in the report; company profiles are provided for 46 companies that raised greater than the median deal size.

image1

Also new in the 2019 version is an analysis of NIH and other grants to ophthalmology. A comprehensive list of retinal disease gene therapies in development and an additional 57 tables and figures are also new in 2019.